Clinical Trial Update: Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689) [Phase 3]

View source ↗

Summary

This entry notes the completion of a long-term safety extension trial of asenapine in adults with schizophrenia who completed the prior protocol P05688 (P05689)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Asenapine (asenapine)

Snippet

Sponsor: Forest Laboratories | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED